Xeris Biopharma Holdings, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 06/08/2026 | Mar 2026Filed 06/08/2026 | Sep 2025Filed 06/11/2025 | Jun 2025Filed 06/08/2026 | Mar 2025Filed 06/08/2026 | Sep 2024Filed 06/11/2025 | Jun 2024Filed 06/11/2025 | Mar 2024Filed 06/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $92 | $83 | $74 | $72 | $60 | $54 | $48 | $41 | |
| −$31 | $2.2 | $0.6 | −$1.9 | −$9.2 | −$16 | −$15 | −$19 | |
| −$0.18 | $0.01 | $0.00 | −$0.01 | −$0.06 | −$0.11 | −$0.10 | −$0.14 | |
| 173 | 178 | 178 | 159 | 152 | 149 | 148 | 141 |
Trend